[go: up one dir, main page]

Treece et al., 1976 - Google Patents

Exacerbation of porphyria during treatment of pulmonary tuberculosis

Treece et al., 1976

Document ID
11786861564705310052
Author
Treece G
Magnussen C
Patterson J
Tschudy D
Publication year
Publication venue
American Review of Respiratory Disease

External Links

Snippet

Several attacks of acute intermittent porphyria complicated the treatment of a patient with pulmonary tuberculosis. To determine whether the attacks were drug-induced, the ability of a variety of antituberculous drugs to induce (delta)-amino-levulinic acid synthetase activity in a …
Continue reading at www.atsjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Groen et al. Evidence for the presence of insulin in blood serum. A method for an approximate determination of the insulin content of blood
Cooney et al. Evaluation of L-asparagine metabolism in animals and man
Brodie et al. The fate of acetanilide in man
Field et al. Studies on the mechanism of ethanol-induced hypoglycemia
Kutt et al. Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity
Feldman et al. Appraisal of the extrapancreatic actions of sulfonylureas
LANDAU Gluconeogenesis and pyruvate metabolism in rat kidney, in vitro
Levin et al. Argininosuccinic aciduria: An inborn error of amino acid metabolism
Herbst et al. Effect of colchicine on intestinal disaccharidases: correlation with biochemical aspects of cellular renewal
Kalant et al. Effect of chronic intake of ethanol on pentobarbital metabolism
LIGHT et al. Aminoacidemia of prematurity: its response to ascorbic acid
AU596296B2 (en) Treatment of diabetes
Owens Jr et al. The metabolism of ethyl alcohol in the rat
Galloway et al. Metabolism, blood levels and rate of excretion of acetohexamide in human subjects
Treece et al. Exacerbation of porphyria during treatment of pulmonary tuberculosis
Clarke et al. Some in vitro studies with BZ-55
Drexler Effect of indole compounds on vitamin B12 utilization
Mabry et al. Leucine-induced hypoglycemia: II. Studies concerning other amino acids and leucine metabolites
Tabachnik et al. Studies on the reduction of sputum viscosity in cystic fibrosis using an orally absorbed protected thiol.
Krakoff et al. Effects of 2-Ethylamino-l, 3, 4 Thiadiazole HCl on Uric Acid Production in Man.
Wagner Glycogen content of isolated white blood cells in glycogen storage disease
Ferrebee et al. Tissue thiamin concentrations and urinary thiamin excretion
Yamamoto et al. Effect of carbon tetrachloride injury on plasma and liver vitamin B12 levels
Singapore Tuberculosis Service/British Medical Research Council Controlled Trial of Intermittent Regimens of Rifampin Plus Isoniazid for Pulmonary Tuberculosis in Singapore: The Results up to 30 Months
Gordon et al. Gluconeogenesis in renal cortical tubules: Effect of phenformin